Bio-Reference Labs (BRLI) Reports In-Line Q4 EPS of 46c
Tweet Send to a FriendGet Alerts BRLI Hot Sheet
Price: $30.75 -1.47%
Revenue Growth %: +7.6%
Financial Fact:
NET REVENUES:: 161.26M
Today's EPS Names:
ANF, DXLG, FL, More
Revenue Growth %: +7.6%
Financial Fact:
NET REVENUES:: 161.26M
Today's EPS Names:
ANF, DXLG, FL, More
Trade BRLI Now!
Bio-Reference Labs (NASDAQ: BRLI) reported Q4 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $176.05 million versus the consensus estimate of $175.46 million.
For earnings history and earnings-related data on Bio-Reference Labs (BRLI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Bio-Reference Labs (BRLI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Pandora (P) Pops Higher on Q1 Results; Expands Listener Base by 2.5M Subs
- salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
